SG48282A1 - Preparation of factor ix - Google Patents
Preparation of factor ixInfo
- Publication number
- SG48282A1 SG48282A1 SG1996008689A SG1996008689A SG48282A1 SG 48282 A1 SG48282 A1 SG 48282A1 SG 1996008689 A SG1996008689 A SG 1996008689A SG 1996008689 A SG1996008689 A SG 1996008689A SG 48282 A1 SG48282 A1 SG 48282A1
- Authority
- SG
- Singapore
- Prior art keywords
- factor
- contained
- preparations
- disclosed
- derived
- Prior art date
Links
- 229960004222 factor ix Drugs 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 3
- 108010076282 Factor IX Proteins 0.000 abstract 6
- 102100022641 Coagulation factor IX Human genes 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 108010048049 Factor IXa Proteins 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66292791A | 1991-03-01 | 1991-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG48282A1 true SG48282A1 (en) | 1998-04-17 |
Family
ID=24659784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996008689A SG48282A1 (en) | 1991-03-01 | 1992-02-26 | Preparation of factor ix |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US6063909A (es) |
| EP (1) | EP0573605B1 (es) |
| JP (1) | JP3418621B2 (es) |
| AT (1) | ATE195877T1 (es) |
| AU (1) | AU671586B2 (es) |
| BR (1) | BR9205700A (es) |
| CA (1) | CA2105282C (es) |
| DE (1) | DE69231401T2 (es) |
| DK (1) | DK0573605T3 (es) |
| ES (1) | ES2150914T3 (es) |
| FI (1) | FI114969B (es) |
| GR (1) | GR3034946T3 (es) |
| MX (1) | MX9200882A (es) |
| NO (1) | NO315856B1 (es) |
| RU (1) | RU2142806C1 (es) |
| SG (1) | SG48282A1 (es) |
| WO (1) | WO1992015324A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG48282A1 (en) * | 1991-03-01 | 1998-04-17 | Centeon Llc | Preparation of factor ix |
| PT658168E (pt) * | 1992-08-27 | 2001-04-30 | Sanquin Bloedvoorziening | Anticorpos especificos para uma proteina hemostatica sua utilizacao para isolamento da proteina intacta composicoes hemostaticas desprovidas de produtos de clivagem proteolitica da proteina |
| DE19506633A1 (de) * | 1995-02-25 | 1996-08-29 | Octapharma Ag | Verfahren zur Herstellung von Faktor IX aus biologischen Quellen |
| AU723521B2 (en) * | 1996-10-31 | 2000-08-31 | Roche Diagnostics Gmbh | Method for the determination of the catalytic activity of factor IXa |
| AU2002226028A1 (en) * | 2000-11-14 | 2002-05-27 | Board Of Regents, Unversity Of Texas Systems | Mutant human factor ix with an increased resistance to inhibition by heparin |
| MXPA05010846A (es) * | 2003-04-09 | 2006-03-30 | Nektar Therapeutics | Tratamiento de hemofilia mediante inhalacion de factores de coagulacion. |
| WO2006017263A1 (en) | 2004-07-12 | 2006-02-16 | Taro Pharmaceutical Industries Ltd. | Topical gel formulation comprising organophosphate insecticide and its preparation thereof |
| US8158139B2 (en) * | 2004-07-12 | 2012-04-17 | Taro Pharmaceuticals North America, Inc. | Topical gel formulation comprising organophosphate insecticide and preparation thereof |
| US7560445B2 (en) | 2005-07-06 | 2009-07-14 | Taro Pharmaceuticals North America, Inc. | Process for preparing malathion for pharmaceutical use |
| WO2011086197A1 (en) | 2010-01-18 | 2011-07-21 | Novo Nordisk Health Care Ag | Purification of blood coagulation factors |
| WO2011121020A1 (en) * | 2010-03-30 | 2011-10-06 | Octapharma Ag | A process for purifying vitamin k dependent proteins such as coagulation factor ix |
| CA2821711C (en) | 2010-12-15 | 2017-10-10 | Baxter International Inc. | Eluate collection using conductivity gradient |
| US9663553B2 (en) | 2014-01-29 | 2017-05-30 | Hemarus Therapeutics Limited | Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
| DE3045153A1 (de) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
| DE3101752A1 (de) * | 1981-01-21 | 1982-08-26 | Behringwerke Ag, 3550 Marburg | "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen" |
| US4447416A (en) * | 1982-04-28 | 1984-05-08 | American National Red Cross | Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy |
| US4379085A (en) * | 1982-05-14 | 1983-04-05 | American National Red Cross | Heat stabilization of plasma proteins |
| EP0118256B1 (en) * | 1983-03-04 | 1992-05-13 | Scripps Clinic And Research Foundation | Immunoadsorbent, and method of recovering vitamin-k dependent protein therewith |
| US5614500A (en) | 1983-03-04 | 1997-03-25 | The Scripps Research Institute | Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
| US5055557A (en) * | 1983-03-04 | 1991-10-08 | Scripps Clinic & Research Foundation | Ultrapurification of factor IX and other vitamin K-dependent proteins |
| DE3473407D1 (en) * | 1983-05-02 | 1988-09-22 | Immuno Ag | Method of inactivating pathogens |
| JPS60132912A (ja) * | 1983-12-21 | 1985-07-16 | Kao Corp | シヤンプ−組成物 |
| ATE74164T1 (de) * | 1985-04-22 | 1992-04-15 | Genetics Inst | Herstellung mit hoher leistung des aktivfaktors ix. |
| US4786726A (en) * | 1986-01-06 | 1988-11-22 | Blood Systems, Inc. | Factor IX therapeutic blood product, means and methods of preparing same |
| FR2600334B1 (fr) | 1986-06-23 | 1989-05-12 | Transgene Sa | Vecteurs d'integration dans les cellules eucaryotes assurant l'expression du facteur ix, lignees celullaires obtenues et procede pour leur preparation |
| US4725673A (en) * | 1986-08-29 | 1988-02-16 | Alpha Therapeutic Corporation | Plasma fraction purification using silica resin bound to a ligand |
| EP0317376B2 (fr) | 1987-10-23 | 1996-04-03 | Centre Regional De Transfusion Sanguine De Lille | Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques |
| JPH01258700A (ja) | 1988-04-05 | 1989-10-16 | Green Cross Corp:The | 血液凝固第４因子の精製方法 |
| DE3826792C1 (es) * | 1988-08-06 | 1989-07-06 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| US4981952A (en) * | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
| DE3914869C1 (es) * | 1989-05-05 | 1990-08-09 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
| AT402261B (de) * | 1991-01-25 | 1997-03-25 | Immuno Ag | Komplex enthaltend den gerinnungsfaktor ix |
| SG48282A1 (en) * | 1991-03-01 | 1998-04-17 | Centeon Llc | Preparation of factor ix |
-
1992
- 1992-02-26 SG SG1996008689A patent/SG48282A1/en unknown
- 1992-02-26 CA CA002105282A patent/CA2105282C/en not_active Expired - Fee Related
- 1992-02-26 BR BR9205700A patent/BR9205700A/pt not_active Application Discontinuation
- 1992-02-26 JP JP50823092A patent/JP3418621B2/ja not_active Expired - Fee Related
- 1992-02-26 EP EP92908513A patent/EP0573605B1/en not_active Expired - Lifetime
- 1992-02-26 DK DK92908513T patent/DK0573605T3/da active
- 1992-02-26 DE DE69231401T patent/DE69231401T2/de not_active Expired - Fee Related
- 1992-02-26 RU RU93053992A patent/RU2142806C1/ru active
- 1992-02-26 ES ES92908513T patent/ES2150914T3/es not_active Expired - Lifetime
- 1992-02-26 WO PCT/US1992/001600 patent/WO1992015324A1/en active IP Right Grant
- 1992-02-26 AT AT92908513T patent/ATE195877T1/de not_active IP Right Cessation
- 1992-02-26 AU AU16429/92A patent/AU671586B2/en not_active Ceased
- 1992-02-28 MX MX9200882A patent/MX9200882A/es unknown
-
1993
- 1993-08-03 US US08/101,175 patent/US6063909A/en not_active Expired - Lifetime
- 1993-09-01 FI FI933814A patent/FI114969B/fi not_active IP Right Cessation
- 1993-09-01 NO NO19933114A patent/NO315856B1/no not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/465,867 patent/US6043215A/en not_active Expired - Lifetime
-
2000
- 2000-03-13 US US09/524,206 patent/US6280729B1/en not_active Expired - Fee Related
- 2000-11-30 GR GR20000402648T patent/GR3034946T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI114969B (fi) | 2005-02-15 |
| NO933114L (no) | 1993-09-01 |
| CA2105282C (en) | 2002-09-24 |
| ES2150914T3 (es) | 2000-12-16 |
| BR9205700A (pt) | 1994-06-28 |
| DK0573605T3 (da) | 2001-01-02 |
| EP0573605A1 (en) | 1993-12-15 |
| AU1642992A (en) | 1992-10-06 |
| NO933114D0 (no) | 1993-09-01 |
| DE69231401T2 (de) | 2001-02-08 |
| EP0573605A4 (en) | 1994-11-23 |
| JP3418621B2 (ja) | 2003-06-23 |
| NO315856B1 (no) | 2003-11-03 |
| US6280729B1 (en) | 2001-08-28 |
| RU2142806C1 (ru) | 1999-12-20 |
| EP0573605B1 (en) | 2000-08-30 |
| US6063909A (en) | 2000-05-16 |
| FI933814A0 (fi) | 1993-09-01 |
| MX9200882A (es) | 1992-09-01 |
| AU671586B2 (en) | 1996-09-05 |
| GR3034946T3 (en) | 2001-02-28 |
| JPH06505494A (ja) | 1994-06-23 |
| DE69231401D1 (de) | 2000-10-05 |
| ATE195877T1 (de) | 2000-09-15 |
| CA2105282A1 (en) | 1992-09-02 |
| WO1992015324A1 (en) | 1992-09-17 |
| US6043215A (en) | 2000-03-28 |
| FI933814A (fi) | 1993-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3034946T3 (en) | Preparation of factor ix. | |
| ES8603271A1 (es) | Un metodo de producir una composicion de interleuquina-2 | |
| KR920000785A (ko) | 새로운 혈소판 응집 억제인자 | |
| EP0410207A3 (en) | Stabilization of highly purified proteins | |
| ZA200005696B (en) | Stable concentrated rare earth carboxylate liquids. | |
| GB2194886B (en) | Medicaments containing tissue plasminogen activator. | |
| ATE81858T1 (de) | 6-thioxanthinderivate. | |
| RU93053992A (ru) | Способ очистки и хранения фактора ix, водный раствор очищенного фактора ix, композиция, содержащая фактор ix, способ лечения | |
| CA2221865A1 (en) | Bradykinin analogs as selective thrombin inhibitors | |
| CA2001552A1 (en) | Cyclophosphamide - sodium bicarbonate lyophilizates | |
| EP0138616A3 (en) | Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them | |
| NO2006006I1 (no) | Aktivert protein C | |
| JPS57134419A (en) | Stable anticoagulant of blood | |
| SE8704832L (en) | Prepn. for dissolving caries - comprises nitrogen-contg. cpds. and sodium hypochlorite | |
| JPS5762218A (en) | Ophthalmic solution | |
| DE68905796D1 (de) | Chromoglycinsaeure-natriumsalz enthaltende aerosolzubereitungen. | |
| SE9502927D0 (sv) | Solution containing IGF-I | |
| AU2601088A (en) | Hypoglycaemic peptides | |
| HUT36658A (en) | Process for improving stability of flowers in vase |